These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 29083021)

  • 1. Sarcoidosis-associated pulmonary hypertension treated with sildenafil - a case report.
    Kacprzak A; Szturmowicz M; Burakowska B; Franczuk M; Kober J; Kurzyna M; Wilk M; Szmit S; Torbicki A; Kuś J
    Adv Respir Med; 2017; 85(5):258-263. PubMed ID: 29083021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies.
    Keir GJ; Walsh SL; Gatzoulis MA; Marino PS; Dimopoulos K; Alonso R; Raposeiras-Roubin S; Renzoni EA; Maher TM; Wells AU; Wort SJ
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Jul; 31(2):82-90. PubMed ID: 25078636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on sarcoidosis-associated pulmonary hypertension.
    Bandyopadhyay D; Humbert M
    Curr Opin Pulm Med; 2020 Sep; 26(5):582-590. PubMed ID: 32740377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil?
    Milman N; Burton CM; Iversen M; Videbaek R; Jensen CV; Carlsen J
    J Heart Lung Transplant; 2008 Mar; 27(3):329-34. PubMed ID: 18342757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin and oral vasodilator therapy in sarcoidosis-associated pulmonary hypertension: a retrospective case series.
    Bonham CA; Oldham JM; Gomberg-Maitland M; Vij R
    Chest; 2015 Oct; 148(4):1055-1062. PubMed ID: 26437815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoidosis associated pulmonary hypertension: an update.
    Samaranayake CB; McCabe C; Wort SJ; Price LC
    Curr Opin Pulm Med; 2021 Sep; 27(5):285-295. PubMed ID: 34127623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dramatic improvement of clinical and hemodynamic parameters of a heart transplant candidate with sildenafil treatment.
    Gerede DM; Sayın T; Vurgun VK; Akbulut IM; Erol C
    Int J Cardiol; 2015 Apr; 185():148-9. PubMed ID: 25795206
    [No Abstract]   [Full Text] [Related]  

  • 8. Sarcoidosis-associated pulmonary hypertension: acute vasoresponsiveness to inhaled nitric oxide and the relation to long-term effect of sildenafil.
    Milman N; Svendsen CB; Iversen M; Videbaek R; Carlsen J
    Clin Respir J; 2009 Oct; 3(4):207-13. PubMed ID: 20298406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sildenafil in heart transplant candidates with pulmonary hypertension.
    de Groote P; El Asri C; Fertin M; Goéminne C; Vincentelli A; Robin E; Duva-Pentiah A; Lamblin N
    Arch Cardiovasc Dis; 2015; 108(6-7):375-84. PubMed ID: 25921840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcoidosis-associated pulmonary hypertension.
    Cordova FC; D'Alonzo G
    Curr Opin Pulm Med; 2013 Sep; 19(5):531-7. PubMed ID: 23912192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcoidosis-associated pulmonary hypertension and lung transplantation for sarcoidosis.
    Shino MY; Lynch Iii JP; Fishbein MC; McGraw C; Oyama J; Belperio JA; Saggar R
    Semin Respir Crit Care Med; 2014 Jun; 35(3):362-71. PubMed ID: 25007088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertension.
    Abston E; Moll M; Hon S; Govender P; Berman J; Farber H
    Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(2):184-191. PubMed ID: 33093782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of sildenafil for pulmonary hypertension in neonates.
    Márquez-González H; Ríos DI; Jean Tron MG; Barajas-Nava LA
    Bol Med Hosp Infant Mex; 2020; 77(4):202-206. PubMed ID: 32713951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of systemic sclerosis and sarcoidosis.
    Godziszewska S; Widuchowska M; Kopeć-Mędrek M; Kucharz EJ
    Wiad Lek; 2016; 69(4):693-694. PubMed ID: 27941212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoidosis-associated pulmonary hypertension: assessment and management.
    Palmero V; Sulica R
    Semin Respir Crit Care Med; 2010 Aug; 31(4):494-500. PubMed ID: 20665399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Sildenafil for Severe Pulmonary Hypertension Developing after Ibuprofen Use in a Neonate.
    Rodriguez-Castano MJ; Aleo E; Arruza L
    Indian Pediatr; 2016 Apr; 53(4):349-50. PubMed ID: 27156554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventional therapy in sarcoidosis-associated pulmonary arterial stenosis and pulmonary hypertension.
    Liu L; Xu J; Zhang Y; Fang L; Chai Y; Niu M; Li S
    Clin Respir J; 2017 Nov; 11(6):906-914. PubMed ID: 26666961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-series.
    Mathijssen H; Huitema MP; Bakker ALM; Mager JJ; Snijder RJ; Grutters JC; Post MC
    Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(1):74-78. PubMed ID: 33093771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of right-ventricular dysfunction in pulmonary arterial hypertension following sildenafil therapy.
    Romano S; Chung J; Farzaneh-Far A
    Eur Heart J; 2015 Aug; 36(30):2018. PubMed ID: 25713316
    [No Abstract]   [Full Text] [Related]  

  • 20. Sickle cell disease, pulmonary hypertension, and sarcoidosis.
    Lehmann LH; Riess H; Sturm I
    Ann Hematol; 2008 Jul; 87(7):591-2. PubMed ID: 18228021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.